BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 20186708)

  • 21. Death of oligodendrocytes mediated by the interaction of nerve growth factor with its receptor p75.
    Casaccia-Bonnefil P; Carter BD; Dobrowsky RT; Chao MV
    Nature; 1996 Oct; 383(6602):716-9. PubMed ID: 8878481
    [TBL] [Abstract][Full Text] [Related]  

  • 22. P53 associates with trk tyrosine kinase.
    Montano X
    Oncogene; 1997 Jul; 15(3):245-56. PubMed ID: 9233759
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The p75 neurotrophin receptor.
    Chao MV
    J Neurobiol; 1994 Nov; 25(11):1373-85. PubMed ID: 7852992
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular Landscape in Infant High-Grade Gliomas: A Single Center Experience.
    Di Ruscio V; Carai A; Del Baldo G; Vinci M; Cacchione A; Miele E; Rossi S; Antonelli M; Barresi S; Caulo M; Colafati GS; Mastronuzzi A
    Diagnostics (Basel); 2022 Feb; 12(2):. PubMed ID: 35204463
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NTRK Fusions Can Co-Occur With H3K27M Mutations and May Define Druggable Subclones Within Diffuse Midline Gliomas.
    Dahl NA; Donson AM; Sanford B; Wang D; Walker FM; Gilani A; Foreman NK; Tinkle CL; Baker SJ; Hoffman LM; Venkataraman S; Vibhakar R
    J Neuropathol Exp Neurol; 2021 Mar; 80(4):345-353. PubMed ID: 33749791
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neurotrophin Signaling in Medulloblastoma.
    Thomaz A; Jaeger M; Brunetto AL; Brunetto AT; Gregianin L; de Farias CB; Ramaswamy V; Nör C; Taylor MD; Roesler R
    Cancers (Basel); 2020 Sep; 12(9):. PubMed ID: 32906676
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pediatric low-grade glioma in the era of molecular diagnostics.
    Ryall S; Tabori U; Hawkins C
    Acta Neuropathol Commun; 2020 Mar; 8(1):30. PubMed ID: 32164789
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dual-Specificity Phosphatases in Neuroblastoma Cell Growth and Differentiation.
    Nunes-Xavier CE; Zaldumbide L; Aurtenetxe O; López-Almaraz R; López JI; Pulido R
    Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30866462
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An agent for optical imaging of TrkC-expressing, breast cancer.
    Kamkaew A; Li F; Li Z; Burgess K
    Medchemcomm; 2017 Oct; 8(10):1946-1952. PubMed ID: 30108715
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unravelling the Mechanism of TrkA-Induced Cell Death by Macropinocytosis in Medulloblastoma Daoy Cells.
    Li C; MacDonald JI; Talebian A; Leuenberger J; Seah C; Pasternak SH; Michnick SW; Meakin SO
    Mol Cell Biol; 2016 Oct; 36(20):2596-611. PubMed ID: 27503856
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular characteristics of pediatric high-grade gliomas.
    Chamdine O; Gajjar A
    CNS Oncol; 2014 Nov; 3(6):433-43. PubMed ID: 25438814
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The neuroimmunology of degeneration and regeneration in the peripheral nervous system.
    DeFrancesco-Lisowitz A; Lindborg JA; Niemi JP; Zigmond RE
    Neuroscience; 2015 Aug; 302():174-203. PubMed ID: 25242643
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma.
    Wu G; Diaz AK; Paugh BS; Rankin SL; Ju B; Li Y; Zhu X; Qu C; Chen X; Zhang J; Easton J; Edmonson M; Ma X; Lu C; Nagahawatte P; Hedlund E; Rusch M; Pounds S; Lin T; Onar-Thomas A; Huether R; Kriwacki R; Parker M; Gupta P; Becksfort J; Wei L; Mulder HL; Boggs K; Vadodaria B; Yergeau D; Russell JC; Ochoa K; Fulton RS; Fulton LL; Jones C; Boop FA; Broniscer A; Wetmore C; Gajjar A; Ding L; Mardis ER; Wilson RK; Taylor MR; Downing JR; Ellison DW; Zhang J; Baker SJ
    Nat Genet; 2014 May; 46(5):444-450. PubMed ID: 24705251
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nerve growth factor in cancer cell death and survival.
    Molloy NH; Read DE; Gorman AM
    Cancers (Basel); 2011 Feb; 3(1):510-30. PubMed ID: 24212627
    [TBL] [Abstract][Full Text] [Related]  

  • 35. STK25 protein mediates TrkA and CCM2 protein-dependent death in pediatric tumor cells of neural origin.
    Costa B; Kean MJ; Ast V; Knight JD; Mett A; Levy Z; Ceccarelli DF; Badillo BG; Eils R; König R; Gingras AC; Fainzilber M
    J Biol Chem; 2012 Aug; 287(35):29285-9. PubMed ID: 22782892
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functional consequences of necdin nucleocytoplasmic localization.
    Lavi-Itzkovitz A; Tcherpakov M; Levy Z; Itzkovitz S; Muscatelli F; Fainzilber M
    PLoS One; 2012; 7(3):e33786. PubMed ID: 22442722
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of critical domains within the tumor suppressor CASZ1 required for transcriptional regulation and growth suppression.
    Virden RA; Thiele CJ; Liu Z
    Mol Cell Biol; 2012 Apr; 32(8):1518-28. PubMed ID: 22331471
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The in vivo contribution of motor neuron TrkB receptors to mutant SOD1 motor neuron disease.
    Zhai J; Zhou W; Li J; Hayworth CR; Zhang L; Misawa H; Klein R; Scherer SS; Balice-Gordon RJ; Kalb RG
    Hum Mol Genet; 2011 Nov; 20(21):4116-31. PubMed ID: 21816949
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Necdin and neurotrophin receptors: interactors of relevance for neuronal resistance to oxidant stress.
    Ingraham CA; Wertalik L; Schor NF
    Pediatr Res; 2011 Apr; 69(4):279-84. PubMed ID: 21150695
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.